Nutritional proteomics: Methods and concepts for research in nutritional science

Annals of Nutrition and Metabolism

Volumn 51, Issue 2, 2007, Pages 99-107

  Schweigert, Florian J ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

Author keywords

Biomarker; Microheterogeneity; Nutriproteomics; Nutritional science; Protein complexes; Proteomics

Indexed keywords

1,4 BENZOQUINONE; CAFFEIC ACID; CHLOROGENIC ACID; DIALLYL DISULFIDE; FERULIC ACID; GALLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; QUINIC ACID; TUMOR NECROSIS FACTOR BINDING PROTEIN;

FOOD ANALYSIS; FUNCTIONAL FOOD; GENE MAPPING; GENETIC HETEROGENEITY; HUMAN; NUTRITION; NUTRITIONAL PROTEOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEOMICS; REVIEW;

BIOLOGICAL MARKERS; CHRONIC DISEASE; DIET; HEALTH STATUS; HUMANS; NUTRITION PHYSIOLOGY; NUTRITIONAL SCIENCES; PROTEOMICS; RESEARCH;

EID: 34250845812     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102101     Document Type: Review

References (85)

1. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 2001;291:1304-1351.
2. Haynes PA, Gygi SP, Figeys D, Aebersold R: Proteome analysis: biological assay or data archive? Electrophoresis 1998;19:1862-1871.
3. Hochstrasser DF, Sanchez JC, Appel RD: Proteomics and its trends facing nature's complexity. Proteomics 2002;2:807-812.
4. Molloy MP, Witzmann FA: Proteomics: technologies and applications. Brief Funct Genomic Proteomic 2002;1:23-39.
5. Tyers M, Mann M: From genomics to proteomics. Nature 2003;422:193-197.
6. Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004;3:301-317.
7. Barnes S, Kim H: Nutriproteomics: identifying the molecular targets of nutritive and non-nutritive components of the diet. J Biochem Mol Biol 2004;37:59-74.
8. Petricoin EF, Liotta LA: Clinical applications of proteomics. J Nutr 2003;133:2476S-2484S.
9. Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N, van Ommen B: Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab 2005;49:355-365.
10. Daniel H, tom Dieck H: Nutrient-gene interactions: a single nutrient and hundreds of target genes. Biol Chem 2004;385:571-583.
11. Davis CD, Milner J: Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 2004;551:51-64.
12. Fuchs D, Winkelmann I, Johnson IT, Mariman E, Wenzel U, Daniel H: Proteomics in nutrition research: principles, technologies and applications. Br J Nutr 2005;94:302-314.
13. Kaput J, Rodriguez RL: Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004;16:166-177.
14. Muller M, Kersten S: Nutrigenomics: goals and strategies. Nat Rev Genet 2003;4:315-322.
15. Mutch DM, Wahli W, Williamson G: Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 2005;19:1602-1616.
16. Trayhurn P: Nutritional genomics - 'nutrigenomics'. Br J Nutr 2003;89:1-2.
17. Anderson NL, Anderson NG: Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998;19:1853-1861.
18. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867.
19. Forterre S, Raila J, Schweigert FJ: Protein profiling of urine from dogs with renal disease using ProteinChip analysis. J Vet Diagn Invest 2004;16:271-277.
20. Gericke B, Koebnick C, Reimann M, Forterre S, Zunft HJF, Schweigert FJ: Influence of hormone replacement therapy on proteomic pattern in serum of postmenopausal women. Maturitas 2005;51:334-342.
21. Petricoin EF, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA: Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002;94:1576-1578.
22. Fuchs D, de Pascual-Teresa S, Rimbach G, Virgili F, Ambra R, Turner R, Daniel H, Wenzel U: Proteome analysis for identification of target proteins of genistein in primary human endothelial cells stressed with oxidized LDL or homocysteine. Eur J Nutr 2005;44:95-104.
23. Gianazza E, Veber D, Eberini I, Buccellato FR, Mutti E, Sironi L, Scalabrino G: Cobalamin (vitamin B 12 ) deficiency-induced changes in the proteome of rat cerebrospinal fluid. Biochem J 2003;374:239-246.
24. Linke T, Ross AC, Harrison EH: Profiling of rat plasma by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry, a novel tool for biomarker discovery in nutrition research. J Chromatogr A 2004;1043:65-71.
25. Tosco A, Siciliano RA, Cacace G, Mazzeo MF, Capone R, Malorni A, Leone A, Marzullo L: Dietary effects of copper and iron deficiency on rat intestine: a differential display proteome analysis. J Proteome Res. 2005;4:1781-1788.
26. Park JY, Seong JK, Paik YK: Proteomic analysis of diet-induced hypercholesterolemic mice. Proteomics 2004;4:514-523.
27. Cesareni G, Ceol A, Gavrila C, Palazzi LM, Persico M, Schneider MV: Comparative interactomics. FEBS Lett 2005;579:1828-1833.
28. McCormick F: Small-molecule inhibitors of cell signaling. Curr Opin Biotechnol 2000;11:593-597.
29. Park D, Lee S, Bolser D, Schroeder M, Lappe M, Oh D, Bhak J: Comparative interactomics analysis of protein family interaction networks using PSIMAP (protein structural interactome map). Bioinformatics 2005;21:3234-3240.
30. Schweigert FJ: Characterisation of protein microheterogeneity and protein complexes using on-chip immunoaffinity purificationmass spectrometry. Brief Funct Genomic Proteomic 2005;4:7-15.
31. Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, Christensen EI: Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol 2002;13:423-430.
32. Lopez F, Pichereaux C, Burlet-Schiltz O, Pradayrol L, Monsarrat B, Esteve JP: Improved sensitivity of biomolecular interaction analysis mass spectrometry for the identification of interacting molecules. Proteomics 2003;3:402-412.
33. Natsume T, Nakayama H, Isobe T: BIA-MSMS: biomolecular interaction analysis for functional proteomics. Trends Biotechnol 2001;19:S28-S33.
34. Schweigert FJ, Wirth K, Raila J: Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDITOF-MS immunoassay. Proteome Sci 2004;2:5.
35. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, Kratzin H, Deeg M, Kuczyk M, Mueller GA, Mueller CA, Flad T: Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid α in renal cancer patients. Lab Invest 2004;84:845-856.
36. Apweiler R, Hermjakob H, Sharon N: On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999;1473:4-8.
37. Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ: Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356:1749-1756.
38. Baumann M, Meri S: Techniques for studying protein heterogeneity and post-translational modifications. Expert Rev Proteomics 2004;1:207-217.
39. Davis BG: Biochemistry. Mimicking post-translational modifications of proteins. Science 2004;303:480-482.
40. Hancock WS: Glycosylation, who cares? J Proteome Res 2002;1:297.
41. Mann M, Jensen ON: Proteomic analysis of post-translational modifications. Nat Biotechnol 2003;21:255-261.
42. Kroll J, Rawel H, Rohn S: A review. Reactions of plant phenolics with food proteins and enzymes under special consideration of covalent bonds. Food Sci Technol Res 2003;9:205-218.
43. Rawel HM, Meidtner K, Kroll J: Binding of selected phenolic compounds to proteins. J Agric Food Chem 2005;53:4228-4235.
44. Rawel HM, Rohn S, Kroll J, Schweigert FJ: Surface enhanced laser desorption ionization-time of flight-mass spectrometry analysis in complex food and biological systems. Mol Nutr Food Res 2005;49:1104-1111.
45. Rawel HM, Rohn S, Kroll J: Influence of a sugar moiety (rhamnosylglucoside) at 3-O position on the reactivity of quercetin with whey proteins. Int J Biol Macromol 2003;32:109-120.
46. Seifert A, Rawel H, Harding SE, Kroll J: Characterization of bovine serum albumin/chlorogenic acid solution mixtures by analytical ultracentrifugation. Prog Colloid Polymer Sci 2004;127:83-88.
47. Rawel H, Kroll J, Haebel S, Peter MG: Reactions of a glucosinolate breakdown product (benzyl isothiocyanate) with myoglobin. Phytochemistry 1998;48:1305-1311.
48. Rohn S, Rawel H, Wollenberger U, Kroll J: Enzymatical behaviour of α-chymotrypsin after derivatization with phenolic compounds. Nahrung 2003;47:325-329.
49. Knowles LM, Milner JA: Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells. J Nutr 2003;133:2901-2906.
50. Dinkova-Kostova AT: Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes. Mini Rev Med Chem 2002;2:595-610.
51. Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB, Breslin PA: Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005;437:45-46.
52. Archakov AI, Govorun VM, Dubanov AV, Ivanov YD, Veselovsky AV, Lewi P, Janssen P: Protein-protein interactions as a target for drugs in proteomics. Proteomics 2003;3:380-391.
53. Jenkins JL, Shapiro R: Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking. Biochemistry 2003;42:6674-6687.
54. Loregian A, Marsden HS, Palu G: Protein-protein interactions as targets for antiviral chemotherapy. Rev Med Virol 2002;12:239-262.
55. Purkey HE, Dorrell MI, Kelly JW: Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma. Proc Natl Acad Sci USA 2001;98:5566-5571.
56. Veselovsky AV, Ivanov YD, Ivanov AS, Archakov AI, Lewi P, Janssen P: Protein-protein interactions: mechanisms and modification by drugs. J Mol Recognit 2002;15:405-422.
57. Gadek TR, Nicholas JB: Small-molecule antagonists of proteins. Biochem Pharmacol 2003;65:1-8.
58. Pagliaro L, Felding J, Audouze K, Nielsen SJ, Terry RB, Krog-Jensen C, Butcher S: Emerging classes of protein-protein interaction inhibitors and new tools for their development. Curr Opin Chem Biol 2004;8:442-449.
59. Grant SG, Husi H: Proteomics of multiprotein complexes: answering fundamental questions in neuroscience. Trends Biotechnol 2001;19:S49-54.
60. Figeys D, McBroom LD, Moran MF: Mass spectrometry for the study of protein-protein interactions. Methods 2001;24:230-239.
61. Nair KS, Jaleel A, Asmann YW, Short KR, Raghavakaimal S: Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol 2004;286:E863-E874.
62. Arthur JM: Proteomics. Curr Opin Nephrol Hypertens 2003;12:423-430.
63. Hanash S: Disease proteomics. Nature 2003; 422:226-232.
64. Ingenbleek Y, Young V: Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994;14:495-533.
65. Palha JA: Transthyretin as a thyroid hormone carrier: function revisited. Clin Chem Lab Med 2002;40:1292-1300.
66. Chang MH, Hua CT, Isaac EL, Litjens T, Hodge G, Karageorgos LE, Meikle PJ: Transthyretin interacts with the lysosome-associated membrane protein (LAMP-1) in circulation. Biochem J 2004;382:481-489.
67. Lasztity N, Biro L, Nemeth E, Pap A, Antal M: Protein status in pancreatitis-transthyretin is a sensitive biomarker of malnutrition in acute and chronic pancreatitis. Clin Chem Lab Med 2002;40:1320-1324.
68. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaften-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW: Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-5890.
69. Schweigert FJ, Sehouli J: Transthyretin, a biomarker for nutritional status and ovarian cancer. Cancer Res 2005;65:1114.
70. Blomhoff R: Transport and metabolism of vitamin A. Nutr Rev 1994;52:S13-S23.
71. Monaco HL: The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000;1482:65-72.
72. Zanotti G, Berni R: Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 2004;69:271-295.
73. Rosales FJ, Chau KK, Haskell MH, Shankar AH: Determination of a cut-off value for the molar ratio of retinol-binding protein to transthyretin (RBP:TTR) in Bangladeshi patients with low hepatic vitamin A stores. J Nutr 2002;132:3687-3692.
74. Blomhoff R, Green MH, Berg T, Norum KR: Transport and storage of vitamin A. Science 1990;250:399-404.
75. Kiernan UA, Tubbs KA, Gruber K, Nedelkov D, Niederkofler EE, Williams P, Nelson RW: High-throughput protein characterization using mass spectrometric immunoassay. Anal Biochem 2002;301:49-56.
76. Zhang Q, Kelly JW: Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 2003;42:8756-8761.
77. Jaconi S, Rose K, Hughes GJ, Saurat JH, Siegenthaler G: Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. J Lipid Res 1995;36:1247-1253.
78. Tajiri T, Ando Y, Hata K, Kamide K, Hashimoto M, Nakamura M, Terazaki H, Yamashita T, Kai H, Haraoka K, Imasato A, Takechi K, Nakagawa K, Okabe H, Ishizaki T: Amyloid formation in rat transthyretin: effect of oxidative stress. Clin Chim Acta 2002;323:129-137.
79. Takaoka Y, Ohta M, Miyakawa K, Nakamura O, Suzuki M, Takahashi K, Yamamura K, Sakaki Y: Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met. Am J Pathol 2004;164:337-345.
80. Malone W, Perloff M, Crowell J, Sigman C, Higley H: Fenretinide: a prototype cancer prevention drug. Expert Opin Investig Drugs 2003;12:1829-1842.
81. Berni R, Clerici M, Malpeli G, Cleris L, Formelli F: Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J 1993;7:1179-1184.
82. Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M: Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 1989;49:6149-6152.
83. Holven KB, Natarajan V, Gundersen TE, Moskaug JO, Norum KR, Blomhoff R: Secretion of N-(4-hydroxyphenyl)retinamideretinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin. Int J Cancer 1997;71:654-659.
84. Schweigert FJ, Steinhagen B, Raila J, Siemann A, Peet D, Buscher U: Concentrations of carotenoids, α-tocopherol and retinol in serum and follicular fluid of women undergoing IVF. Hum Reprod 2003;18:1259-1264.
85. Gericke B, Raila J, Sehouli J, Haebel S, Konsgen D, Mustea A, Schweigert FJ: Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer 2005;5:133.